(CLDX) Celldex Therapeutics Weekly charts technical analysis
(CLDX) Celldex Therapeutics Weekly charts technical analysis Weekly analysis of Celldex Therapeutics | Buy/Sell Celldex Therapeutics
Celldex Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Celldex Therapeutics is 842010
| Date | Closing Price | Open | High | Low | Volume |
| 15 Thu Jan 2026 | 25.69 | 27.20 | 27.20 | 25.15 | 3.909 Mn |
| 09 Fri Jan 2026 | 27.38 | 27.04 | 28.27 | 25.15 | 3.514 Mn |
| 02 Fri Jan 2026 | 27.01 | 26.33 | 27.65 | 25.51 | 3.387 Mn |
| 26 Fri Dec 2025 | 26.40 | 25.47 | 27.92 | 25.39 | 1.779 Mn |
| 19 Fri Dec 2025 | 25.60 | 27.90 | 27.90 | 24.97 | 4.178 Mn |
| 12 Fri Dec 2025 | 27.51 | 29.85 | 30.50 | 27.29 | 4.879 Mn |
| 05 Fri Dec 2025 | 29.45 | 26.60 | 29.83 | 25.69 | 3.91 Mn |
| 28 Fri Nov 2025 | 27.02 | 26.08 | 27.06 | 25.06 | 1.918 Mn |
| 21 Fri Nov 2025 | 25.92 | 25.46 | 26.50 | 24.53 | 4.055 Mn |
| 14 Fri Nov 2025 | 25.55 | 23.28 | 25.62 | 22.10 | 5.071 Mn |
Indicators analysis of Celldex Therapeutics (CLDX)
Price action analysis of Celldex Therapeutics ( (CLDX) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Celldex Therapeutics ( (CLDX) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Celldex Therapeutics ( (CLDX) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Celldex Therapeutics ( (CLDX) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Celldex Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Celldex Therapeutics in short term but the sell signal is initial and weak.
Celldex Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Celldex Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Celldex Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 26.72 and Celldex Therapeutics (CLDX) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Celldex Therapeutics (CLDX) stock. Volume based technical analysis of Celldex Therapeutics (CLDX) stock is negative.
Celldex Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Weekly charts
Price action analysis of Celldex Therapeutics ( (CLDX) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Celldex Therapeutics ( (CLDX) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Celldex Therapeutics ( (CLDX) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Celldex Therapeutics ( (CLDX) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Celldex Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Celldex Therapeutics in short term but the sell signal is initial and weak.
Celldex Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Celldex Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Celldex Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 26.72 and Celldex Therapeutics (CLDX) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Celldex Therapeutics (CLDX) stock. Volume based technical analysis of Celldex Therapeutics (CLDX) stock is negative.
Celldex Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

